HCPLive Network


Latest Issue
Other Issues
Men with HIV Develop More Plaque in Coronary Arteries
By Rachel Lutz
Men with HIV have more noncalcified plaque in their arteries than their uninfected counterparts.
Serious Liver Disease Rates Higher Among Coinfected Patients
By Catherine Kolonko
Study results show hepatic decompensation is more common in people who have both HIV and hepatitis C virus (HCV) compared to those infected only with HCV, an indication that early HCV treatment among coinfected patients is needed.
How Obamacare Will Affect HIV/AIDS Prevention
By Katie Eder
Noting successful HIV/AIDS prevention efforts rely on early diagnosis, an analysis estimates that improved access to health insurance through the Affordable Care Act will increase the number of patients getting tested for HIV by nearly 500,000 over a 5-year period, though that impact would be amplified if all US states opted to expand Medicaid coverage.
Combination Antiretroviral Therapy Effective for Preventing Spread of HIV between Cells
By Rachel Lutz
During experiments with cell-to-cell and cell-free transmissions, researchers showed that existing drugs are effective in suppressing the spread of HIV.
Hemophiliac Patients with HIV Show Increased Amount of Immune Cells Targeting HIV
By Jacqueline Gray
Study results suggest that patients with long-term HIV who also have hemophilia may have an increased proportion of immune cells in their blood that target HIV.
Hepatitis C Saliva Tests May Show a False-Negative Result if HIV Is Also Present
By Eileen Oldfield
Saliva tests for detecting anti–hepatitis C antibodies may not be as effective in patients who also have an HIV infection.
New Details about Hepatitis C Protein May Aid Development of Vaccine
By Catherine Kolonko
Scientists have mapped the structure of a hepatitis C virus surface protein that is responsible for binding to host liver cells, leading to virus entry.
Gene Therapy Shows Promise in Neutralizing HIV
By Davey James
Researchers safely infuse engineered immune cells in groundbreaking gene therapy study.